Joby Aviation Scores a Win in Its Legal Battle Against Rival Archer Aviation. Will It Help the Slumping Stock?

A California court partially narrowed Joby Aviation’s claims against Archer while dismissing all of Archer’s counterclaims, though both sides can refile amended complaints by June 22 and June 29, respectively. The ruling is a relative win for Joby, but the article argues the bigger investment issue remains FAA commercial approval for both eVTOL air-taxi developers. The litigation may create short-term volatility, but the approval timeline is the main stock driver.

Analysis

The near-term market reaction should be driven less by the legal merits and more by asymmetry in distraction. For both names, litigation is a capital-allocation tax: management time, legal spend, and incremental disclosure risk all matter more now than the eventual courtroom outcome. The fact that one side’s claims were trimmed while the other’s were dismissed creates a tactical relative-value edge for the company with fewer issues to rehabilitate, but it does not change the core investment variable: certification progress.

Second-order, this kind of dispute can make counterparties, airports, suppliers, and pilots more conservative. If a third party fears being dragged into discovery or becoming collateral in a trade-secret fight, it may slow site agreements, hiring, or component flow for both companies over the next 1-2 quarters. That effect is more damaging for the weaker balance-sheet/operator because eVTOL commercialization is already a timing game; a few months of slippage can move revenue recognition and funding needs materially.

The bigger risk is that investors underprice how binary FAA milestones are relative to legal headlines. A court loss here may shave sentiment, but a certification delay or execution miss can reset equity value by multiples. Conversely, if either company shows a clean regulatory cadence over the next 6-12 months, litigation noise should fade quickly and the more speculative seller shorting on legal risk will be forced to cover.

The contrarian angle is that the market may be overestimating the enduring value of the lawsuits as a thesis driver. These cases are likely to become a transitory headline unless they uncover evidence that directly impairs certification or supply chain integrity. If that doesn’t happen, the right framework is not ‘who wins in court,’ but ‘who can keep partners and regulators focused long enough to reach commercial launch first.’

Key Decisions for Investors

• Relative-value trade: long JOBY / short ACHR for 4-8 weeks, targeting legal overhang dispersion and the cleaner downside skew in the dismissed counterclaims; stop if ACHR shows materially better FAA/certification updates.
• Buy near-dated put spreads on ACHR into any litigation-related rally, because sentiment can gap on headlines but the core catalyst remains binary FAA progress; structure for 2-3 month expiry to avoid paying for long-dated time decay.
• For investors already long either name, hedge event risk with a small notional short against the peer rather than index hedges; pair risk is more directly tied to the court/certification narrative than market beta.
• Avoid adding outright equity exposure until the next FAA milestone window; the risk/reward is poor for cash longs when a regulatory slip can matter more than favorable litigation noise over the next 1-2 quarters.
• If one company shows a meaningful certification or partnership update while the peer remains in litigation churn, rotate aggressively to the operational winner; that setup can justify a 1-2x relative multiple re-rate versus the laggard.